您的位置：
Tremelimumab
(2S,5S,8S,11R,14S,17S,20S,23S,26S,29S)-17-[(2S)-2-Butanyl]-29-[{[(2S)-5-carbamimidamido-1-hydroxy-1-{[(2S,3R)-3-hydroxy-1-oxo-2-butanyl]imino}-2-pentanyl]imino}(hydroxy)methyl]-23-(2-carboxyethyl)-6,1
5,18,21,24,27-hexahydroxy-2-(2-hydroxy-2-iminoethyl)-20-isobutyl-5-methyl-8,14,26-tris[2-(methylsulfanyl)ethyl]-9,10-dioxo-11-(selanylmethyl)-3,4,7,12,13,16,19,22,25,28-decaazadotriaconta-6,15,18,21,2
4,27-hexaene-1,32-dioic acid
≥98% ( Chemicell/科米赛尔)
| CAS号 | 745013-59-6 | 试剂别名 | CTLA-4 单抗 |
| 分子式 | C57H100N16O19S3Se | ||
| 分子量 | 1488.66 | ||
| 英文名称： | (2S,5S,8S,11R,14S,17S,20S,23S,26S,29S)-17-[(2S)-2-Butanyl]-29-[{[(2S)-5-carbamimidamido-1-hydroxy-1-{[(2S,3R)-3-hydroxy-1-oxo-2-butanyl]imino}-2-pentanyl]imino}(hydroxy)methyl]-23-(2-carboxyethyl)-6,1 5,18,21,24,27-hexahydroxy-2-(2-hydroxy-2-iminoethyl)-20-isobutyl-5-methyl-8,14,26-tris[2-(methylsulfanyl)ethyl]-9,10-dioxo-11-(selanylmethyl)-3,4,7,12,13,16,19,22,25,28-decaazadotriaconta-6,15,18,21,2 4,27-hexaene-1,32-dioic acid |
| 英文别名： | Ticilimumab;Tremelimumab;(2S,5S,8S,11R,14S,17S,20S,23S,26S,29S)-17-[(2S)-2-Butanyl]-29-[{[(2S)-5-carbamimidamido-1-hydroxy-1- |
| 中文别名： | CTLA-4 单抗 |
| CAS No.： | 745013-59-6 |
| 分子式： | C57H100N16O19S3SE |
| 分子量： | 1488.66 |
| 纯度： | ≥98% |
沪公网安备 31011502020044号
危险化学品经营许可证
水涛